Anika Therapeutics
ANIK | NASDAQ
$12.92
-$0.48 (-3.58%)
At close: Nov 16, 2026, 4:00 PM ET
$12.92
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-3.58%
(1D)Rating
42.8
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #448/1021 (Top 44%)
Key Statistics
Market Data
Market Cap $173.07M
1D Range
12.84 13.48
52W Range
9.13 22.03
Valuation (TTM)
PE -99.38
PB 1.26
EV/EBITDA 53.74
Valuation (NTM)
Forward PE 12.07
Forward PEG 0.37
Price Target $21.00
Cash Flow
FCF Yield 1.3%
SBC Adj. FCF Yield -7.4%
SBC Impact -661.3%
Margins
Gross Margin 63.4%
Operating Margin -2.1%
FCF Margin 1.9%
Growth (CAGR)
Revenue 3Y | 5Y -8.9% |
-3.1%
Dil EPS 3Y | 5Y 108.0% |
5.6%
FCF 3Y | 5Y 361.9% |
2.3%
Returns
ROA -0.9%
ROE -1.3%
ROIC -0.4%
Financial Health
Net Cash
$20.39M
Current Ratio 3.86
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Anika Therapeutics, Inc. is a company dedicated to joint preservation, innovating and providing early intervention orthopedic care across the globe, including the United States and Europe. Their core ...
Sector Healthcare
Industry Medical - Specialties
Employees 235
IPO Date May 3, 1993
Website www.anika.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 6, 2026
EPS
$0.29
Miss -30.95%
YoY:
+625.00% REV
$30.59M
Beat +3.94%
YoY:
+9.98%Next Earnings
Feb 25, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
2
Consensus
Buy
Price Target
$21.00
Upside
+62.54%
Buy (2)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove ANIK